Item 16. Form 10-K Summary
5K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary
The optional summary in Item 16 has not been included in this Form 10-K.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| MASCO CORPORATION | ||
| By: | /s/ John G. Sznewajs | |
| John G. Sznewajs Vice President, Chief Financial Officer |
February 11, 2020
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated.
| Principal Executive Officer: | ||||
| /s/ Keith J. Allman | President and Chief Executive Officer and Director | |||
| Keith J. Allman | ||||
| Principal Financial Officer: | ||||
| /s/ John G. Sznewajs | Vice President, Chief Financial Officer | |||
| John G. Sznewajs | ||||
| Principal Accounting Officer: | ||||
| /s/ John P. Lindow | Vice President, Controller and Chief Accounting Officer | |||
| John P. Lindow | ||||
| /s/ J. Michael Losh | Chairman of the Board | |||
| J. Michael Losh | ||||
| /s/ Richard A. Manoogian | Chairman Emeritus | |||
| Richard A. Manoogian | ||||
| /s/ Mark R. Alexander | Director | |||
| Mark R. Alexander | February 11, 2020 | |||
| /s/ Marie A. Ffolkes | Director | |||
| Marie A. Ffolkes | ||||
| /s/ Christopher A. O'Herlihy | Director | |||
| Christopher A. O'Herlihy | ||||
| /s/ Donald R. Parfet | Director | |||
| Donald R. Parfet | ||||
| /s/ Lisa A. Payne | Director | |||
| Lisa A. Payne | ||||
| /s/ John C. Plant | Director | |||
| John C. Plant | ||||
| /s/ Charles K. Stevens, III | ||||
| Charles K. Stevens, III | Director | |||
| /s/ Reginald M. Turner, Jr. | Director | |||
| Reginald M. Turner, Jr. |
MASCO CORPORATION
SCHEDULE II. VALUATION AND QUALIFYING ACCOUNTS
For the Years Ended December 31, 2019**,** 2018 and 2017
| (In Millions) | ||||||||||||||||||||||
| Column A | Column B | Column C | Column D | Column E | ||||||||||||||||||
| Additions | ||||||||||||||||||||||
| Description | Balance at Beginning of Period | Charged to Costs and Expenses | Charged to Other Accounts | Deductions | Balance at End of Period | |||||||||||||||||
| Allowances for doubtful accounts, deducted from accounts receivable in the balance sheet (d): | ||||||||||||||||||||||
| 2019 | $ | 5 | $ | 1 | $ | — | $ | (2 | ) | (a) | $ | 4 | ||||||||||
| 2018 | $ | 4 | $ | 3 | $ | — | $ | (2 | ) | (a) | $ | 5 | ||||||||||
| 2017 | $ | 5 | $ | 1 | $ | — | $ | (2 | ) | (a) | $ | 4 | ||||||||||
| Valuation allowance on deferred tax assets: | ||||||||||||||||||||||
| 2019 | $ | 43 | $ | — | $ | — | $ | (5 | ) | (b) | $ | 38 | ||||||||||
| 2018 | $ | 47 | $ | — | $ | — | $ | (4 | ) | (c) | $ | 43 | ||||||||||
| 2017 | $ | 45 | $ | — | $ | 2 | (d) | $ | — | $ | 47 |
| (a) | Deductions, representing uncollectible accounts written off, less recoveries of accounts written off in prior years. |
| (b) | $5 million net reduction to valuation allowance recorded as an income tax benefit. |
| (c) | $3 million net reduction to valuation allowance recorded as an income tax benefit and $1 million reduction recorded primarily in other comprehensive income (loss). |
| (d) | $2 million adjustment to the valuation allowance was recorded primarily in other comprehensive income (loss). |
Previous: Item 15. Exhibits and Financial Statement Schedules.
Sponsor Sponsor this sector. One slot per industry, shown on every filing in it. Details